| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 22,262 | 20,541 | 19,919 | 19,607 | | Cost of Revenue | 5,494 | 5,228 | 4,285 | 4,961 | | | Gross Profit | 16,768 | 15,313 | 15,634 | 14,646 | | | Operating Expenses | | Research Development | 3,110 | 3,138 | 2,701 | 3,023 | | Selling General and Administrative | 9,847 | 10,066 | 10,025 | 10,268 | | Non Recurring |
-
|
-
|
-
| 23,501 | | Others | 118 | 272 | 272 | 273 | | | | Total Operating Expenses |
-
|
-
|
-
| 37,065 | | | | Operating Income or Loss | 3,693 | 1,837 | 2,636 | (22,419) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 90 | (74) | 34 | 59 | | Earnings Before Interest And Taxes | 3,783 | 1,763 | 2,670 | (22,360) | | Interest Expense |
-
| (119) | 119 | 251 | | Income Before Tax | 3,783 | 1,882 | 2,551 | (22,611) | | Income Tax Expense | 1,516 | 748 | 1,280 | 1,233 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 2,267 | 1,134 | 1,271 | (23,844) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 2,267 | 1,134 | 1,271 | (23,844) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $2,267 | $1,134 | $1,271 | ($23,844) |
|
0.03% Nasdaq 
Income Statement
